Acylated exendin-4 compounds
US9012398B2 · kind B2 · utility
4Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2012 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Oct 10, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides Exendin-4 compounds derivatized at a lysine 14 residue to give an acylated lysine, pharmaceutical compositions comprising such compounds, and the use of such compositions for treating diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.